Brazil prepares to have the first genetic bank of cannabis

By João Negromonte with information from Estadão

An important milestone is emerging on the horizon of research and therapeutic use of cannabis in Brazil. As reported by Estadão, the Federal University of Viçosa (UFV) is pioneering a path by requesting authorization from the National Health Surveillance Agency (Anvisa) for the cultivation of five thousand cannabis plants, an initiative that could result in the country's first genetic bank. 

UFV's goal is to genetically characterize the various plant variants, allowing for a deeper understanding of their chemical compositions. This is crucial because the content of cannabinoids, such as cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), varies according to the plant variant. Each disease, in turn, requires specific amounts of these substances for a more effective treatment. Currently, Brazil faces a scenario of uncertainty, with little official information about the available variants. 

In an interview with Estadão, agronomist Derly José Henriques da Silva, a specialist in plant genetics and ecophysiology at UFV, leads this ambitious project. He emphasizes that the genetic bank will not only benefit research and the development of medicinal therapies based on cannabis but will also provide support to families and associations producing medicinal products. 

"Currently, we have no official information about the variants, we live in a gray area. We want to support the families and associations producing medicinal products; there are many families with problems," Silva emphasizes. 

One of the complexities of cannabis cultivation is that even genetically characterized variants in other countries may exhibit different characteristics when grown in Brazil. Variation in environmental factors, such as temperature, light, water, and soil, has a significant impact on the chemical composition of the plant. To overcome this challenge, UFV plans to establish partnerships with cannabis genetic banks in different countries, creating a global knowledge network. 

In addition to therapeutic applications, cannabis has vast potential in the industry, being used in perfume production and in the manufacture of products by breweries. Hemp, a cannabis variant, is a valuable source of fibers used in the production of textiles, ropes, and building materials. However, genetic diversity is essential to optimize the plant's use in all these applications. 

Research on cannabis is becoming increasingly relevant, and the creation of Brazil's first genetic bank of cannabis represents a significant advancement. With this initiative, the country seeks to position itself as an active participant in global cannabis research, connecting with a network of scientists and researchers worldwide. Anvisa has already confirmed receipt of UFV's request, marking the beginning of a promising chapter in cannabis research in Brazil, with the potential to positively impact health and industry.